Valuation: Vineet Laboratories Limited

Market Cap 558M 5.82M 5.13M 4.86M 4.38M 8.26M 8.37M 58.11M 22.36M 285M 21.86M 21.38M 915M P/E 2024
43.6x
P/E 2025 -1.42x
Enterprise Value 956M 9.97M 8.78M 8.31M 7.51M 14.15M 14.33M 99.48M 38.28M 488M 37.42M 36.61M 1.57B EV / Sales 2024
587,502x
EV / Sales 2025 890,202x
Free-Float
62.66%
Yield 2024 *
-
Yield 2025 -
08-25 Vineet Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
07-21 Vineet Laboratories Limited Announces Cessation of Gaddam Venkata Ramana to Hold the Office of Managing Director, Effective July 21, 2026 CI
05-29 Vineet Laboratories Limited Announces Resignation of Ramesh Kumar Bandari from Company Secretary and Compliance Officer and Ceases to Be Key Managerial Personnel, Effective May 29, 2026 CI
02-14 Vineet Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
02-07 Vineet Laboratories Limited Approves Appointment of Jasmin Kunal Tailor as Independent Director CI
12-17 Vineet Laboratories says rights issue price set at 30 rupees per share RE
11-27 Vineet Laboratories Gets Board Nod to Raise Up to INR300 Million via Rights Issue MT
11-27 Vineet Laboratories to raise funds up to 300 million rupees via rights issue RE
11-24 Vineet Laboratories to consider rights issue RE
11-08 Vineet Laboratories Limited Announces Resignation of Hari Priya Yerukalapudi as Independent Director, Effective November 08, 2025 CI
16/09/25 Vineet Laboratories Limited Approves the Appointment of Premananda Reddy Vennapusa as Non-Executive Director, Effective from September 15, 2025 CI
22/07/25 Vineet Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
12/05/25 Vineet Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 CI
1 day+2.27%
1 week+8.27%
Current month-5.23%
1 month-3.04%
3 months+11.50%
6 months+23.25%
Current year+1.63%
1 week 33.7
Extreme 33.7
38.31
1 month 33.7
Extreme 33.7
39.91
Current year 28
Extreme 28
43.56
1 year 28
Extreme 28
51.84
3 years 25.35
Extreme 25.35
88.95
5 years 25.35
Extreme 25.35
91.25
10 years 25.35
Extreme 25.35
124.7
Manager TitleAgeSince
Director of Finance/CFO 76 01/01/2021
Human Resources Officer - -
Comptroller/Controller/Auditor - -
Director TitleAgeSince
Director/Board Member 57 10/11/2016
Director/Board Member 76 10/11/2016
Chairman 73 16/11/2020
Change 5-day change 1-year change 3-year change Capi.($)
+2.27%+8.27% - - 7.35M
-1.16%+1.57%+53.23%+117.19% 1,056B
-0.58%-1.08%+43.60%+71.62% 645B
-0.11%-0.74%+13.64%+77.48% 465B
-2.10%-1.00%+74.68%+42.96% 368B
-0.06%-3.88%+34.32%+40.74% 335B
-0.79%+2.01%+19.82%+28.48% 275B
-1.19%-1.21%+9.82%+12.15% 255B
-0.31%+4.14%+49.86%+58.80% 229B
-0.74%-0.82%+35.26%+102.61% 188B
Average -0.40%+0.12%+37.13%+61.34% 423.98B
Weighted average by Cap. -0.77%+0.30%+40.79%+73.14%

Financials

2024 2025
Net sales 1.51K 15.74 13.86 13.14 11.86 22.35 22.64 157.17 60.48 771.76 59.12 57.83 2.47K 769.53 8.03 7.07 6.7 6.05 11.39 11.54 80.12 30.83 393.4 30.14 29.48 1.26K
Net income 10.27M 107K 94.33K 89.37K 80.69K 152K 154K 1.07M 412K 5.25M 402K 393K 16.83M -202M -2.11M -1.85M -1.76M -1.59M -2.99M -3.03M -21.02M -8.09M -103M -7.91M -7.73M -331M
Net Debt 441M 4.6M 4.05M 3.83M 3.46M 6.53M 6.61M 45.88M 17.66M 225M 17.26M 16.88M 722M 397M 4.14M 3.65M 3.46M 3.12M 5.88M 5.96M 41.37M 15.92M 203M 15.56M 15.22M 651M
Logo Vineet Laboratories Limited
Vineet Laboratories Limited is an India-based company engaged in the business of drug intermediates and bulk drugs. The Company specializes in pharmaceutical intermediates and fine chemicals. Its active pharmaceutical ingredient (API) intermediates products include Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, and Piroctone Olanine. Its fine chemicals and reagents include Isopropyl-beta-D-thiogalactopyranoside, 4-Nitrophenyl phosphate disodium salt, 5-Bromo-4-chloro-3-indolyl-beta-D-galactopyranoside (X-Gal), 5-Acetyl thiophene-2-carboxilic acid, n-Butyl Lithium, n-Butyl magnesium chloride, 3-Furaldehyde, 3-bromofuran, 1-methyl-imidazole-2-carboxaldehyde, 6-Aminouracil, Ethyldiazo acetate, and Phenylboronic acid. The Company also exports API intermediates, fine chemicals, and custom synthesis molecules.
Employees
57
Date Price Change Volume
30/09/26 ₹37.32 +2.27% 11,314
29/09/26 ₹36.49 +4.56% 29,599
28/09/26 ₹34.90 +0.98% 13,479
25/09/26 ₹34.56 -1.12% 28,711
24/09/26 ₹34.95 -0.20% 534,999